Objectives: To evaluate the patient population over a 3-year period and to compare it to observations of the population at the same clinic over a period of 15 years.

Material And Methods: Records of patients receiving dental implants in the Department of Oral Surgery and Stomatology, University of Bern, between January 2014 and December 2016 were analyzed and then compared with data from patients treated between 2002 and 2004 and between 2008 and 2010. Patients were analyzed for demographics and for indications for therapy, as well as for presence or absence and type of complications. Inserted implants were analyzed for type, length, and diameter, as well as for the number and type of associated tissue regeneration procedures.

Results: Analysis revealed a continuous linear increase in the average age of patients seeking implant treatment. The most common indication for implant therapy was a single-tooth gap (STG) (50.5%), followed by distal extension situations (22.3%) and extended edentulous gaps (20.5%). A total of 60.8% of implants placed needed some type of bone augmentation, and 83.5% of implants placed in the anterior maxilla required simultaneous augmentation. Staged guided bone regeneration (GBR) was only necessary in 7% of the cases. Implant failure rates remained low at 0.6%, with postoperative hematomas being the most common postoperative complication (13.4%).

Conclusions: The rising demand for dental implants continues as the patient population ages. Single-tooth gaps remained consistently the most common indication for implant therapy in recent years. Proper case selection and evidence-based surgical protocols are essential for high success rates.

Download full-text PDF

Source
http://dx.doi.org/10.1111/clr.13523DOI Listing

Publication Analysis

Top Keywords

implant therapy
12
patient population
8
dental implants
8
common indication
8
indication implant
8
implant
5
implants
5
analysis trends
4
trends implant
4
therapy
4

Similar Publications

Efficacy and safety of chemotherapy combined with iodine-125 seed brachytherapy for intermediate and advanced oncogenic driver gene-negative non-small cell lung cancer.

Brachytherapy

January 2025

Department of Radiology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of life Sciences and Medicine, University of Science and Technology, Hefei, Anhui 230022, PR China. Electronic address:

Purpose: To compare the effectiveness and safety of CT-guided iodine-125 seed brachytherapy in conjunction with chemotherapy against chemotherapy alone for the management of intermediate and advanced non-small cell lung cancer (NSCLC) lacking oncogenic driving genes.

Methods And Materials: Retrospective analysis was conducted on clinical data from 128 patients diagnosed with intermediate and advanced non-small cell lung cancer who received iodine-125 combined with chemotherapy or chemotherapy alone due to the absence of oncogenic driver gene mutations. The patients in two groups were compared at 6-month follow-up for objective remission rate (ORR), Disease control rate (DCR), local progression-free survival (LPFS), overall survival (OS), clinical symptom improvement, and adverse events.

View Article and Find Full Text PDF

Background: Risk stratification for sudden cardiac death (SCD) in patients with nonischemic cardiomyopathy (NICM) remains challenging.

Objectives: This study aimed to investigate the impact of epicardial adipose tissue (EAT) on SCD in NICM patients.

Methods: Our study cohort included 173 consecutive patients (age 53 ± 14 years, 73% men) scheduled for primary prevention implantable cardioverter-defibrillators (ICDs) implantation who underwent preimplant cardiovascular magnetic resonance.

View Article and Find Full Text PDF

Current guidelines recommend cardioverter-defibrillator (ICD) programming, including faster detection rates, longer detection durations, and strict discrimination for supraventricular tachycardia (SVT) to prevent unnecessary ICD treatment. This delayed-style ICD programming could lead to a rise in the possibility of VF undersensing. To avoid this risk, an innovative algorithm known as VF Therapy Assurance (VFTA; Abbott, Sylmar, CA) has been developed.

View Article and Find Full Text PDF

Background: The most effective way to treat patients following a first ICD therapy is unclear. We hypothesised that following first ICD therapy, combining different treatment strategies would be associated with a reduction in the risk of subsequent therapy compared to single strategies alone.

Methods: Data was collected from consecutive patients undergoing ICD implantation at King's College Hospital between January 2009 and December 2019.

View Article and Find Full Text PDF

Background: Accurate prediction for survival in individualized patients with cardiac resynchronization therapy with a defibrillator (CRT-D) is difficult.

Methods: We analyzed the New Japan cardiac device treatment registry (JCDTR) database to develop a survival prediction model for CRT-D recipients.

Results: Four hundred and eighty-two CRT-D recipients, at the implantation year 2018-2021, with a QRS width ≥120 ms and left ventricular ejection fraction (LVEF) ≤35% at baseline, were analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!